Market Access
How can biotech survive its funding winter?
Some may argue that VCs and public markets have turned against biotech, but the reality is they have become much more sceptical.
News
Novartis issues a life sciences warning in a 'G-Zero' world
Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."
News
FDA seeks changes to GLP-1, flu shot labels
The FDA has asked manufacturers of GLP-1 drugs used for weight loss to remove warnings of suicidal thinking, but added warnings to flu shots.
Market Access
Changes to UK’s VPAG: Non-submissions should be a key metric...
Whatever people think of changes to the UK’s pricing deal, VPAG, judging the difference they make should include monitoring non-submissions to NICE.
News
Sentynl gets first FDA approval for rare disease Menkes
Children with a devastating, rare disorder of copper metabolism, called Menkes disease, now have an FDA-approved treatment for the first time.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
